Trademarkia Logo

Canada

C$
eBioparticle
DEFAULT - SEARCHED

Last Applicant/ Owned by

Angany Inc.

873 Rue Saint-Jean, bureau 200Québec

QUEBEC

CA

G1R1R2

Serial Number

2013410 filed on 21st Feb 2020

Correspondent Address

LAPOINTE ROSENSTEIN MARCHAND MELANÇON, L.L.P./S.E.N.C.R.L.

1 Place Ville MarieSuite 1300MONTREAL

QUEBEC

CA

H3B0E6

eBioparticle

Trademark usage description

chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies f Read More

Classification Information


Class [001]
Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, diagnostic, therapeutic and treatment of cancer, allergies, autoimmune disease, infection diseases.


Classification kind code

11

Class [005]
Diagnostic proteins for clinical or medical laboratory analysis; proteins for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for use in cancer, allergies, autoimmune disease, infection disease; pharmaceutical products for use in the fields of allergy, cancer, infectious diseases and immune diseases; pharmacological agents able to effect immunotherapy with specific attributes of potency and safety.


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical research and development; software as a service (SAAS) provider in the field of providing pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) featuring computer software platforms for use in the field of pharmacological and pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) featuring computer software platforms for use in the field of pharmacological and pharmaceutical applications that is an immunomodulatory vector on which biologic targets determine the pertinence and use of these pharmacological agents.


Classification kind code

11

Mark Details


Serial Number

2013410

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 14
on 2th Jan 2025
Default Notice Sent
Submitted for opposition 22
on 14th Jun 2024
Search Recorded
Submitted for opposition 20
on 14th Jun 2024
Examiner's First Report
Submitted for opposition 48
on 23rd Jan 2024
Agent Changed
Submitted for opposition 287
on 7th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 11th Mar 2020
Formalized
Submitted for opposition 1
on 24th Feb 2020
Created
Submitted for opposition 30
on 21st Feb 2020
Filed